Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

According to FDA, Hurricane Helen caused a supply disruption of IV solutions from Baxter’s facility in North Carolina.

Health authorities say they are continuing to manage the shortage and supply of IV fluids as a priority. Doctors are fighting ...

ICU Medical (ICUI) and Otsuka are launching a joint venture focused on boosting IV solutions production and development in North America. Read more here.

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

Recent quality and operational issues at Smiths, which originated before it was purchased, greatly reduced ICU’s gross margin after the acquisition. These issues have required additional spending to ...

An intravenous (IV) fluid shortage in the wake of Hurricane Helene is continuing after a major North Carolina factory was ...

U.S. hospitals are experiencing a shortage of IV fluids, triggered by a disruption at Baxter's North Carolina plant following Hurricane Helene. As hospitals have scrambled to conserve supplies, at ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...